MCWS
MDNA

McKinley Carter Wealth Services’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

McKinley Carter Wealth Services’s Portfolio MDNA Stock Details MDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-79,259
Closed -$23.4K – 308
2023
Q3 		$23.4K Hold
79,259
– – ﹤0.01% 292
2023
Q2 		$38.2K Hold
79,259
– – ﹤0.01% 296
2023
Q1 		$49.9K Hold
79,259
– – ﹤0.01% 295
2022
Q4 		$36.3K Hold
79,259
– – ﹤0.01% 288
2022
Q3 		$66K Hold
79,259
– – 0.01% 281
2022
Q2 		$92K Hold
79,259
– – 0.01% 287
2022
Q1 		$101K Buy
79,259
+66,665
+529% +$104K 0.01% 288
2021
Q4 		$21K Sell
12,594
-19,643
-61% -$40.7K ﹤0.01% 288
2021
Q3 		$89K Hold
32,237
– – 0.01% 284
2021
Q2 		$97K Buy
32,237
+7,143
+28% +$26.4K 0.01% 284
2021
Q1 		$102K Hold
25,094
– – 0.01% 282
2020
Q4 		$117K Buy
+25,094
New +$101K 0.02% 262

Other funds holding MDNA

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
NDSI
Newman Dignan & Sheerar Inc Providence, Rhode Island $523M AUM 26.16% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

McKinley Carter Wealth Services's MDNA Position: Q4 2023 in Review

McKinley Carter Wealth Services sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q4 2023, closing a stake of 79,259 shares — an estimated $23.4K sold.

McKinley Carter Wealth Services first reported a position in MDNA in Q4 2020 and held it in 12 quarters. The position peaked at $117K in Q4 2020. 3 funds tracked by Wall St. Rank hold MDNA as of Q4 2023.

  • McKinley Carter Wealth Services reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q4 2023 after selling out during the quarter.
  • McKinley Carter Wealth Services sold 79,259 Medicenna Therapeutics Corp. Common Shares shares in Q4 2023, an estimated $23.4K.
  • McKinley Carter Wealth Services first reported a position in Medicenna Therapeutics Corp. Common Shares in Q4 2020 and held it in 12 quarters.
  • McKinley Carter Wealth Services's Medicenna Therapeutics Corp. Common Shares position peaked at $117K in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q4 2023.

Based on McKinley Carter Wealth Services's 13F filing for Q4 2023, filed 7 Feb 2024.